150 related articles for article (PubMed ID: 32751583)
1. Biopharmaceutical Assessment of Dexamethasone Acetate-Based Hydrogels Combining Hydroxypropyl Cyclodextrins and Polysaccharides for Ocular Delivery.
Mazet R; García-Otero X; Choisnard L; Wouessidjewe D; Verdoot V; Bossard F; Díaz-Tomé V; Blanc-Marquis V; Otero-Espinar FJ; Fernandez-Ferreiro A; Gèze A
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32751583
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Combined Cyclodextrin and Hydrogel Formulation for Ocular Delivery of Dexamethasone Acetate by Means of Experimental Designs.
Mazet R; Choisnard L; Levilly D; Wouessidjewe D; Gèze A
Pharmaceutics; 2018 Dec; 10(4):. PubMed ID: 30513707
[TBL] [Abstract][Full Text] [Related]
3. Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging.
Luaces-Rodríguez A; Díaz-Tomé V; González-Barcia M; Silva-Rodríguez J; Herranz M; Gil-Martínez M; Rodríguez-Ares MT; García-Mazás C; Blanco-Mendez J; Lamas MJ; Otero-Espinar FJ; Fernández-Ferreiro A
Int J Pharm; 2017 Aug; 528(1-2):714-722. PubMed ID: 28634142
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis.
Díaz-Tomé V; Luaces-Rodríguez A; Silva-Rodríguez J; Blanco-Dorado S; García-Quintanilla L; Llovo-Taboada J; Blanco-Méndez J; García-Otero X; Varela-Fernández R; Herranz M; Gil-Martínez M; Lamas MJ; González-Barcia M; Otero-Espinar FJ; Fernández-Ferreiro A
J Pharm Sci; 2018 May; 107(5):1342-1351. PubMed ID: 29305870
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone eye drops containing γ-cyclodextrin-based nanogels.
Moya-Ortega MD; Alves TF; Alvarez-Lorenzo C; Concheiro A; Stefánsson E; Thorsteinsdóttir M; Loftsson T
Int J Pharm; 2013 Jan; 441(1-2):507-15. PubMed ID: 23149258
[TBL] [Abstract][Full Text] [Related]
8. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
[TBL] [Abstract][Full Text] [Related]
9. In Situ Gel Formulation for Enhanced Ocular Delivery of Nepafenac.
Shelley H; Rodriguez-Galarza RM; Duran SH; Abarca EM; Babu RJ
J Pharm Sci; 2018 Dec; 107(12):3089-3097. PubMed ID: 30170009
[TBL] [Abstract][Full Text] [Related]
10. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
[TBL] [Abstract][Full Text] [Related]
11. Effect of Formulation Variables and Gamma Sterilization on Transcorneal Permeation and Stability of Proniosomal Gels as Ocular Platforms for Antiglaucomal Drug.
Sayed S; Abdelmoteleb M; Amin MM; Khowessah OM
AAPS PharmSciTech; 2020 Feb; 21(3):87. PubMed ID: 32016607
[TBL] [Abstract][Full Text] [Related]
12. Effect of 2-hydroxypropyl-beta-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate.
Usayapant A; Karara AH; Narurkar MM
Pharm Res; 1991 Dec; 8(12):1495-9. PubMed ID: 1808612
[TBL] [Abstract][Full Text] [Related]
13. Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine.
Aktaş Y; Unlü N; Orhan M; Irkeç M; Hincal AA
Drug Dev Ind Pharm; 2003 Feb; 29(2):223-30. PubMed ID: 12648019
[TBL] [Abstract][Full Text] [Related]
14. Improving corneal permeability of dexamethasone using penetration enhancing agents: First step towards achieving topical drug delivery to the retina.
Thareja A; Leigh T; Hakkarainen JJ; Hughes H; Alvarez-Lorenzo C; Fernandez-Trillo F; Blanch RJ; Ahmed Z
Int J Pharm; 2024 Jun; ():124305. PubMed ID: 38852749
[TBL] [Abstract][Full Text] [Related]
15. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.
Ahn JH; Kim HD; Abuzar SM; Lee JY; Jin SE; Kim EK; Hwang SJ
Int J Pharm; 2017 Aug; 529(1-2):608-616. PubMed ID: 28694094
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
Jansook P; Pichayakorn W; Muankaew C; Loftsson T
Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
18. Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation.
Janga KY; Tatke A; Balguri SP; Lamichanne SP; Ibrahim MM; Maria DN; Jablonski MM; Majumdar S
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1039-1050. PubMed ID: 29475386
[TBL] [Abstract][Full Text] [Related]
19. Tailored nanostructured platforms for boosting transcorneal permeation: Box-Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization.
Elsayed I; Sayed S
Int J Nanomedicine; 2017; 12():7947-7962. PubMed ID: 29133980
[TBL] [Abstract][Full Text] [Related]
20. Positron Emission Tomography for the Development and Characterization of Corneal Permanence of Ophthalmic Pharmaceutical Formulations.
Fernández-Ferreiro A; Silva-Rodríguez J; Otero-Espinar FJ; González-Barcia M; Lamas MJ; Ruibal A; Luaces-Rodriguez A; Vieites-Prado A; Sobrino T; Herranz M; García-Varela L; Blanco-Mendez J; Gil-Martínez M; Pardo M; Moscoso A; Medín-Aguerre S; Pardo-Montero J; Aguiar P
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):772-780. PubMed ID: 28146242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
